Current Signal Transduction Therapy
Curr Signal Transduct Ther
Immunologists, Medicinal Chemists, Neurologists, Oncologists, Pathologists, Pharmacologists, Scientists
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.
No associations affiliated with this journal
Bentham Science Publishers Ltd.
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Author Submission Guidelines
To see more details about Current Signal Transduction Therapy, Subscribe Now!